LobbyingPierre Fabre Pharmaceuticals lobbying by quarter
Pierre Fabre Pharmaceuticals's latest lobbying report covers Q2 2026, at $40K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q3 2025; the issues it reports most are Pharmacy and Health Issues.
Pierre Fabre Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $10K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $60K | 2 |
| Q2 2026 | $40K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$80K · 3 reports
- Health issues$80K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE3 reports
- Food & Drug Administration (FDA)1 reports
- Health & Human Services, Dept of (HHS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Brownstein Hyatt Farber Schreck | $80K | 4 quarters |
| Farragut Partners | $80K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CONSTANTINE HINGSON | Chief of Staff, Senator Dan Coats; Counsel/Legislative Director, Senator Judd Gregg; General Counsel, Senator Elizabeth Dole | Q2 2026 |
| DYLAN MOORE | Intern/Staff Assistant, Speaker John Boehner (OH-8); Legislative Assistant/Legislative Director/Deputy Chief of Staff, Rep. Larry Bucshon (IN-8); Intern, Rep. Mike Turner (OH-10) | Q2 2026 |
| JEFFERY C. MORTIER | Prof Staff on E&C Cmte, LA Rep Whitfield and Intern Devin Nunes | Q2 2026 |
| JEFF MACKINNON | LD & LA Rep. Joe Barton (RTexas) | Q2 2026 |
| SARAH WALTER | Former Legislative Director/Chief Counsel, Sen. John Breaux | Q2 2026 |
| LAUREN ALEXANDRA MISH | Intern, Rep. Brian Fitzpatrick (PA-01); Intern, Department of Health and Human Services in the Office of Global Affairs | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Farragut Partners | $40K |
| 07/16for Q2 | Brownstein Hyatt Farber Schreck | Under $5,000 |
| 04/20for Q1 | Farragut Partners | $40K |
| 04/15for Q1 | Brownstein Hyatt Farber Schreck | $20K |
| 02/24for Q1 | Farragut Partners | Under $5,000 |
| 01/16for Q4 2025 | Brownstein Hyatt Farber Schreck | $50K |
| 25/10/17for Q3 2025 | Brownstein Hyatt Farber Schreck | $10K |
| 25/10/06for Q3 2025 | Brownstein Hyatt Farber Schreck | Under $5,000 |